Pilot testing of an out-of-country medical care questionnaire with screening and cost analysis of preemptive isolation for carbapenem-resistant enterobacteriaceae in a large canadian health region

Infection Control and Hospital Epidemiology

Volumn 35, Issue 4, 2014, Pages 450-451

  Rajapakse, Nipunie ^a   Vayalumkal, Joseph ^a   Lam Li, Debbie ^a   Pearce, Craig ^a   Rees, Gwynne ^a   Kamhuka, Linda ^a   Peirano, Gisele ^b   Pidhorney, Corrinne ^a   Ledgerwood, Donna ^a   Alfieri, Nancy ^a   Hope, Karen ^a   Gregson, Dan ^b,c,d   Pitout, Johann ^b,c   Louie, Thomas ^a,c,d   Conly, John ^a,b,c,d  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; COMPUTERIZED PROVIDER ORDER ENTRY; ECONOMIC ASPECT; ENTEROBACTERIACEAE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LETTER; QUESTIONNAIRE; TRAVEL; ANTIBIOTIC RESISTANCE; CANADA; COST; DRUG EFFECTS; ECONOMICS; ENTEROBACTERIACEAE INFECTIONS; ISOLATION AND PURIFICATION; PILOT STUDY; PRIMARY PREVENTION; TRANSMISSION; UNITED STATES;

CARBAPENEM DERIVATIVE;

CANADA; CARBAPENEMS; COSTS AND COST ANALYSIS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; PILOT PROJECTS; PRIMARY PREVENTION; QUESTIONNAIRES; TRAVEL; UNITED STATES;

EID: 84895822256     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/675616     Document Type: Letter

References (10)

1. Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009;30: 447-452.
2. Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848-855.
3. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK. Emergence and spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011:53:532-540.
4. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-1106.
5. Jacob JT, Klein E, Laxminarayan R, et al. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 62(09);165-170.
6. Brink A, Coetzee J, Clay C, et al. The spread of carbapenemresistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention. S Afr Med J 2102;102(7):599-601.
7. Calgary Economic Development. Demographics. http://www.calgaryeconomicdevelopment.com/research/ demographicspopulation/overview. Accessed August 8, 2013.
8. Government of Alberta. Tourism in Calgary area and tourism destination 2010: a summary of 2010 visitor numbers and characteristics. http://tpr.alberta.ca/tourism/statistics/docs /PersonvisitsCalgaryandArea2010.pdf. February 2012. Accessed October 8, 2013.
9. Conterno LO, Shymanski J, Ramotar K, Toye B, Zvonar R, Roth V. Impact and cost of infection control measures to reduce nosocomial transmission of extended spectrum B-lactamaseproducing organisms in a non-outbreak setting. J Hosp Inf 2007; 65:354-360.
10. Bank of Canada. Inflation calculator. http://www.bankofcanada.ca/rates/related/inflation-calculator/. Accessed April 28, 2013.